|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.There was no reported device malfunction and the device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina and occlusion are listed in the xience alpine everolimus eluting coronary stent system, instructions for use as known patient effects.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
|
It was reported that the procedure was performed to treat a lesion in the proximal right coronary artery (rca).On (b)(6) 2018, the patient presented with st elevation myocardial infarction (stemi) and a 3.5 x 23 mm xience alpine stent was implanted in the proximal rca.On (b)(6) 2018, the patient was re-hospitalized for chest pain [angina].On (b)(6) 2018, percutaneous coronary intervention of the proximal rca [occlusion] was performed for additional treatment.No additional information was provided.
|